Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

13.17

+0.22 (1.70%)

At close: May 29, 2026, 4:00 PM EDT

13.01

-0.16 (-1.21%)

After-hours: May 29, 2026, 7:41 PM EDT

Amneal Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	181.32	127.93	-73.88	-48.72	-254.79	20.17
Depreciation & Amortization	206.6	223.57	236.19	229.4	240.18	233.41
Stock-Based Compensation	33.51	31.95	27.77	26.82	31.85	28.41
Other Adjustments	142.42	161.05	109.08	185.26	107.81	93.43
Change in Receivables	-97.7	-120.57	-162.64	126.29	-79.72	-23.62
Changes in Inventories	-128.72	-87.03	-130.53	-126.18	-102.4	-49.02
Changes in Other Operating Activities	-61.8	3.08	289.1	-47.29	122.17	-60.96
Operating Cash Flow	305.84	339.99	295.1	345.58	65.1	241.82
Operating Cash Flow Growth	-0.35%	15.21%	-14.61%	430.84%	-73.08%	-36.20%
Capital Expenditures	-98.58	-98.84	-60.34	-46.8	-48.8	-50.94
Sale of Property, Plant & Equipment	1.57	2.09	-	-	-	-
Purchases of Intangible Assets	-19.16	-15.51	-14.65	-22.39	-41.8	-1.7
Payments for Business Acquisitions	-	-	-	-	-84.71	-146.54
Proceeds from Business Divestments	-	-	11.99	-	-	-
Other Investing Activities	-	-	-	-	1	5
Investing Cash Flow	-116.18	-112.26	-63	-69.19	-174.31	-194.18
Short-Term Debt Issued	-	218	48	219	85	-
Net Short-Term Debt Issued (Repaid)	-	218	48	219	85	-
Long-Term Debt Issued	134.67	2,695	-	217.73	-	-
Long-Term Debt Repaid	-2,717	-2,812	-188.92	-414.08	-123.27	-78.09
Net Long-Term Debt Issued (Repaid)	-2,582	-116.76	-188.92	-196.35	-123.27	-78.09
Issuance of Common Stock	1.93	1.96	1.15	0.45	0.66	0.85
Repurchase of Common Stock	-44.94	-22.28	-7.95	-2.38	-3.57	-2.66
Net Common Stock Issued (Repurchased)	-43.02	-20.32	-6.8	-1.93	-2.91	-1.81
Other Financing Activities	-126.58	-112.45	-64.08	-233.3	-65.44	-58.23
Financing Cash Flow	-51.42	-31.53	-211.79	-212.57	-106.62	-138.12
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-2.23	-1.68	-1	0.07	-5.68	0.1
Net Cash Flow	136.01	194.52	19.31	63.88	-221.51	-90.38
Free Cash Flow	207.26	241.15	234.76	298.78	16.31	190.88
Free Cash Flow Growth	-14.05%	2.72%	-21.43%	1732.42%	-91.46%	-39.82%
FCF Margin	6.80%	7.99%	8.40%	12.48%	0.74%	9.12%
Free Cash Flow Per Share	0.64	0.74	0.76	1.70	0.11	1.26
Levered Free Cash Flow	-2,543	214.08	76.62	-52.22	42.89	5.03
Unlevered Free Cash Flow	351.63	402.95	669.24	256.39	113.68	170.7

SEC Filings: 10-K · 10-Q